i-manager Publications

Improved Immunotherapy Techniques using Nano Technology to Treat Targeted Cancer

N. Aparna*, M. Kriya Sakthi**, S. Atheena Milagi Pandian***, Rashika Murugan****, N. Sri Manoj Kumar*****

*-***** Atheenapandian Private Limited, Tamilnadu, India.

Periodicity:April - June'2024
DOI : https://doi.org/10.26634/jfet.19.3.20548

Abstract

Immunotherapy, a promising cancer treatment method, faces challenges such as off-target effects and limited efficacy. Researchers are utilizing nanotechnology to enhance the accuracy and effectiveness of immunotherapy. In a clinical trial, nanoparticles were used to directly carry immunomodulatory drugs to tumor locations, enhancing cytotoxic T cell activation and preventing tumor growth. Patients receiving nanoparticle-enhanced immunotherapy experienced longer progression-free survival times and higher response rates than those receiving standard immunotherapy alone. This study demonstrates how nanotechnology is revolutionizing immunotherapy approaches for focused cancer treatment.

Keywords

Immunotherapy, Cytotoxic T cell, Nanotechnology, Nanoparticle, Cancer Treatment.

How to Cite this Article?

Aparna, N., Sakthi, M. K., Pandian, S. A. M., Murugan, R., and Kumar, N. S. M. (2024). Improved Immunotherapy Techniques using Nano Technology to Treat Targeted Cancer. i-manager’s Journal on Future Engineering & Technology, 19(3), 1-9. https://doi.org/10.26634/jfet.19.3.20548

References

[1]. Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016). Nanoparticle-based medicines: A review of FDA-approved materials and clinical trials to date. Pharmaceutical Research, 33, 2373-2387.

[2]. Chen, D. S., & Mellman, I. (2013). Oncology meets immunology: The cancer-immunity cycle. Immunity, 39(1), 1-10.

[3]. Hodi, F. S., O'day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., & Urba, W. J. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. New England Journal of Medicine, 363(8), 711-723.

[4]. Irvine, D. J., & Dane, E. L. (2020). Enhancing cancer immunotherapy with nanomedicine. Nature Reviews Immunology, 20(5), 321-334.

[5]. June, C. H., O'Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018). CAR T cell immunotherapy for human cancer. Science, 359(6382), 1361-1365.

[6]. Li, S. D., & Huang, L. (2008). Pharmacokinetics and biodistribution of nanoparticles. Molecular Pharmaceutics, 5(4), 496-504.

[7]. Matsumura, Y., & Maeda, H. (1986). A new concept f or macromolecular therapeutics i n cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Research, 46(12_Part_1), 6387-6392.

[8]. Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., & Grupp, S. A. (2014). Chimeric antigen receptor T cells for sustained remissions in leukemia. New England Journal of Medicine, 371(16), 1507-1517.

[9]. Mellman, I., Coukos, G., & Dranoff, G. (2011). Cancer immunotherapy comes of age. Nature, 480(7378), 480- 489.

[10]. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2020). Nanocarriers as an emerging platform for cancer therapy. Nano-Enabled Medical Applications, 61-91.

[11]. Ribas, A., & Wolchok, J. D. (2018). Cancer immunotherapy using checkpoint blockade. Science, 359(6382), 1350-1355.

[12]. Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., & Sznol, M. (2012). Safety, activity, and immune correlates of anti–PD-1 antibody in cancer. New England Journal of Medicine, 366(26), 2443-2454.

[13]. Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. (2016). Analysis of nanoparticle delivery to tumours. Nature Reviews Materials, 1(5), 1-12.

[14]. Zhang, C., Wang, W., Liu, T., Wu, Y., Guo, H., Wang, P., & Yuan, Z. (2012). Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Biomaterials, 33(7), 2187-2196.

[15]. Zhang, L., Gu, F. X., Chan, J. M., Wang, A. Z., Langer, R. S., & Farokhzad, O. C. (2008). Nanoparticles in medicine: Therapeutic applications and developments. Clinical Pharmacology & Therapeutics, 83(5), 761-769.

If you have access to this article please login to view the article or kindly login to purchase the article

Single Article

	North Americas,UK, Middle East,Europe		India	Rest of world
	USD	EUR	INR	USD-ROW
Online	15	15

ADD TO CART

Options for accessing this content:

If you would like institutional access to this content, please recommend the title to your librarian.
If you already have i-manager's user account: Login above and proceed to purchase the article.
New Users: Please register, then proceed to purchase the article.